| 000 | 01847 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516043935.0 | ||
| 264 | 0 | _c20111128 | |
| 008 | 201111s 0 0 eng d | ||
| 022 | _a1744-7666 | ||
| 024 | 7 |
_a10.1517/14656566.2011.589837 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSalama, Rania O | |
| 245 | 0 | 0 |
_aAdvances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease? _h[electronic resource] |
| 260 |
_bExpert opinion on pharmacotherapy _cAug 2011 |
||
| 300 |
_a1913-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadministration & dosage |
| 650 | 0 | 4 |
_aAdrenergic beta-2 Receptor Agonists _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBronchodilator Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCholinergic Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aDelayed-Action Preparations _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xtrends |
| 650 | 0 | 4 |
_aDrugs, Investigational _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntellectual Property |
| 650 | 0 | 4 |
_aPhosphodiesterase 4 Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdrug therapy |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 700 | 1 | _aYoung, Paul M | |
| 700 | 1 | _aRogueda, Philippe | |
| 700 | 1 | _aLallement, Arthur | |
| 700 | 1 | _aIliev, Ilian | |
| 700 | 1 | _aTraini, Daniela | |
| 773 | 0 |
_tExpert opinion on pharmacotherapy _gvol. 12 _gno. 12 _gp. 1913-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14656566.2011.589837 _zAvailable from publisher's website |
| 999 |
_c20967894 _d20967894 |
||